Ligand validation:8TVT

P15: 2,5,8,11,14,17-HEXAOXANONADECAN-19-OL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8TVT_P15_A_521	36%	63%	0.167	0.858	0.53	0.89	-	-	3	0	100%	0.77
6W1D_P15_A_526	17%	64%	0.274	0.852	0.64	0.74	-	-	9	0	100%	0.91
6WIH_P15_A_523	8%	72%	0.289	0.772	0.61	0.46	-	-	15	0	100%	0.86
6BJ5_P15_C_401	66%	65%	0.133	0.937	0.72	0.64	1	-	2	0	100%	1
6DVR_P15_A_502	57%	81%	0.103	0.885	0.49	0.34	-	-	0	0	95%	0.95
4A5X_P15_B_1082	55%	42%	0.156	0.923	0.75	1.46	-	1	1	0	100%	1
7Y0G_P15_K_301	54%	61%	0.136	0.899	0.53	0.96	-	-	0	0	100%	1
5CE5_P15_A_403	53%	73%	0.15	0.91	0.52	0.54	-	-	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.